Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health

PARIS and CAMBRIDGE, Mass., Aug. 3, 2020 /PRNewswire/ -- ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, notes a new academic publication describing the creation of...

from PR Newswire: https://ift.tt/31btssC